pubmed-article:2539769 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:2539769 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:2539769 | lifeskim:mentions | umls-concept:C0006826 | lld:lifeskim |
pubmed-article:2539769 | lifeskim:mentions | umls-concept:C0314657 | lld:lifeskim |
pubmed-article:2539769 | lifeskim:mentions | umls-concept:C1866227 | lld:lifeskim |
pubmed-article:2539769 | lifeskim:mentions | umls-concept:C0220898 | lld:lifeskim |
pubmed-article:2539769 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:2539769 | pubmed:dateCreated | 1989-5-23 | lld:pubmed |
pubmed-article:2539769 | pubmed:abstractText | We herein propose that specific chromosomal aberrations associated with specific neoplasms are not necessarily inherited as a constitutional trait. High-risk individuals may have a tendency to undergo specific somatic mutations or chromosomal rearrangements at a relatively low frequency in all tissues as mosaicism. This may potentiate the development of specific somatic cancers. Our hypothesis may be applicable to both hereditary and sporadic types of neoplasms. | lld:pubmed |
pubmed-article:2539769 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2539769 | pubmed:language | eng | lld:pubmed |
pubmed-article:2539769 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:2539769 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:2539769 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:2539769 | pubmed:issn | 0250-7005 | lld:pubmed |
pubmed-article:2539769 | pubmed:author | pubmed-author:PathakSS | lld:pubmed |
pubmed-article:2539769 | pubmed:author | pubmed-author:HopwoodV LVL | lld:pubmed |
pubmed-article:2539769 | pubmed:author | pubmed-author:DhaliwalM KMK | lld:pubmed |
pubmed-article:2539769 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:2539769 | pubmed:volume | 9 | lld:pubmed |
pubmed-article:2539769 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:2539769 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:2539769 | pubmed:pagination | 17-9 | lld:pubmed |
pubmed-article:2539769 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
pubmed-article:2539769 | pubmed:meshHeading | pubmed-meshheading:2539769-... | lld:pubmed |
pubmed-article:2539769 | pubmed:meshHeading | pubmed-meshheading:2539769-... | lld:pubmed |
pubmed-article:2539769 | pubmed:meshHeading | pubmed-meshheading:2539769-... | lld:pubmed |
pubmed-article:2539769 | pubmed:meshHeading | pubmed-meshheading:2539769-... | lld:pubmed |
pubmed-article:2539769 | pubmed:meshHeading | pubmed-meshheading:2539769-... | lld:pubmed |
pubmed-article:2539769 | pubmed:meshHeading | pubmed-meshheading:2539769-... | lld:pubmed |
pubmed-article:2539769 | pubmed:meshHeading | pubmed-meshheading:2539769-... | lld:pubmed |
pubmed-article:2539769 | pubmed:meshHeading | pubmed-meshheading:2539769-... | lld:pubmed |
pubmed-article:2539769 | pubmed:meshHeading | pubmed-meshheading:2539769-... | lld:pubmed |
pubmed-article:2539769 | pubmed:articleTitle | Genetic susceptibility, somatic mosaicisms and predisposition to human cancer. | lld:pubmed |
pubmed-article:2539769 | pubmed:affiliation | Department of Cell Biology, University of Texas M.D. Anderson Cancer Center, Houston 77030. | lld:pubmed |
pubmed-article:2539769 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:2539769 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
pubmed-article:2539769 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |